Richard J. ARMITAGE

Person

Bainbridge Island, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
BCMA antigen binding proteins
- Patent number 10,465,009
- Issue date Nov 5, 2019
- Amgen Inc.
- Richard J. Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
BCMA Antigen binding proteins
- Patent number 10,220,090
- Issue date Mar 5, 2019
- Amgen Inc.
- Richard J. Armitage
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human CD30 ligand antigen binding proteins
- Patent number 9,926,373
- Issue date Mar 27, 2018
- Novo Nordisk A/S
- Mette D. Andersen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-interleukin-4 receptor antibodies
- Patent number 9,587,026
- Issue date Mar 7, 2017
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
BCMA antigen binding proteins
- Patent number 9,243,058
- Issue date Jan 26, 2016
- Amgen, Inc.
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-interleukin-4 receptor antibodies
- Patent number 8,679,487
- Issue date Mar 25, 2014
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ULBP2 polypeptides
- Patent number 8,410,252
- Issue date Apr 2, 2013
- Immunex Corporation
- David J Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ULBP antibodies
- Patent number 7,807,796
- Issue date Oct 5, 2010
- Immunex Corporation
- David J Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ULBP antibodies
- Patent number 7,427,669
- Issue date Sep 23, 2008
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD40-Ligand lacking native-pattern glycosylation
- Patent number 7,405,270
- Issue date Jul 29, 2008
- Immunex Corporation
- Richard J. Armitage
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Mouse CD40 ligand-specific antibodies and hybridomas
- Patent number 7,309,489
- Issue date Dec 18, 2007
- Immunex Corporation
- Richard J. Armitage
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CD30 ligand
- Patent number 7,232,660
- Issue date Jun 19, 2007
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ULBP antibodies
- Patent number 7,193,058
- Issue date Mar 20, 2007
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ULBP DNA and polypeptides
- Patent number 6,774,224
- Issue date Aug 10, 2004
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD30 ligand
- Patent number 6,667,039
- Issue date Dec 23, 2003
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
ULBP DNA and polypeptides
- Patent number 6,653,447
- Issue date Nov 25, 2003
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Defective CD4+T-cells that express active CD40-L
- Patent number 6,613,320
- Issue date Sep 2, 2003
- Immunex Corporation
- Melanie K. Spriggs
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
ULBP DNA and polypeptides
- Patent number 6,458,350
- Issue date Oct 1, 2002
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding CD40 ligand, a cytokine that binds CD40
- Patent number 6,410,711
- Issue date Jun 25, 2002
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of CD40 ligand, a cytokine that binds CD40, to stimulate hybrid...
- Patent number 6,391,637
- Issue date May 21, 2002
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of augmenting a vaccine response by administering CD40 ligand
- Patent number 6,290,972
- Issue date Sep 18, 2001
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inhibiting CD40L binding to CD40 with soluble monomeric...
- Patent number 6,264,951
- Issue date Jul 24, 2001
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD30 ligand oligomers and polypeptides
- Patent number 6,143,869
- Issue date Nov 7, 2000
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of individuals exhibiting defective CD40L
- Patent number 6,106,832
- Issue date Aug 22, 2000
- Immunex Corporation
- Melanie K. Spriggs
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD40 ligand polypeptide
- Patent number 6,087,329
- Issue date Jul 11, 2000
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
DNA encoding CD40 ligand, a cytokine that binds CD40
- Patent number 5,981,724
- Issue date Nov 9, 1999
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies to CD40 ligand, pharmaceutical composition co...
- Patent number 5,961,974
- Issue date Oct 5, 1999
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant soluble CD40 ligand polypeptide and pharmaceutical comp...
- Patent number 5,962,406
- Issue date Oct 5, 1999
- Immunex Corporation
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isolated Epstein-Barr virus BZLF2 proteins that bind MHC class II ....
- Patent number 5,925,734
- Issue date Jul 20, 1999
- Immunex Corporation
- Mark Alderson
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies to CD40
- Patent number 5,801,227
- Issue date Sep 1, 1998
- William C. Fanslow
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS
- Publication number 20220112295
- Publication date Apr 14, 2022
- Amgen Inc.
- METTE D. ANDERSEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF
- Publication number 20190023798
- Publication date Jan 24, 2019
- IMMUNEX CORPORATION
- Richard J. ARMITAGE
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
BCMA ANTIGEN BINDING PROTEINS
- Publication number 20190008974
- Publication date Jan 10, 2019
- Amgen Inc.
- Richard J. ARMITAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF
- Publication number 20180171016
- Publication date Jun 21, 2018
- Immunex Corporation
- Richard J. ARMITAGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCMA ANTIGEN BINDING PROTEINS
- Publication number 20170165373
- Publication date Jun 15, 2017
- Amgen Inc.
- Richard J. ARMITAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF
- Publication number 20170137526
- Publication date May 18, 2017
- Immunex Corporation
- Richard J. ARMITAGE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human CD30 Ligand Antigen Binding Proteins
- Publication number 20160039940
- Publication date Feb 11, 2016
- Amgen Inc.
- Mette D. Andersen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BCMA ANTIGEN BINDING PROTEINS
- Publication number 20150344583
- Publication date Dec 3, 2015
- Amgen Inc.
- Richard J. ARMITAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BCMA ANTIGEN BINDING PROTEINS
- Publication number 20140161828
- Publication date Jun 12, 2014
- Amgen Inc.
- Richard J. ARMITAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF
- Publication number 20140154267
- Publication date Jun 5, 2014
- IMMUNEX CORPORATION
- Richard J. ARMITAGE
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ULBP ANTIBODIES
- Publication number 20110281789
- Publication date Nov 17, 2011
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF
- Publication number 20110002913
- Publication date Jan 6, 2011
- Immunex Corporation
- RICHARD J. ARMITAGE
- A01 - AGRICULTURE FORESTRY ANIMAL HUSBANDRY HUNTING TRAPPING FISHING
Information Patent Application
ULBP antibodies
- Publication number 20090324597
- Publication date Dec 31, 2009
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD30 Ligand
- Publication number 20090264349
- Publication date Oct 22, 2009
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULBP antibodies
- Publication number 20080008715
- Publication date Jan 10, 2008
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD 30 ligand
- Publication number 20040241758
- Publication date Dec 2, 2004
- Immunex Corporation
- Raymond G. Goodwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULBP antibodies
- Publication number 20040235058
- Publication date Nov 25, 2004
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD40-Ligand lacking native-pattern glycosylation
- Publication number 20040006006
- Publication date Jan 8, 2004
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ULBP DNA and polypeptides
- Publication number 20030147847
- Publication date Aug 7, 2003
- Immunex Corporation
- David J. Cosman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD40-Ligand lacking native-pattern glycosylation
- Publication number 20030144182
- Publication date Jul 31, 2003
- Richard J. Armitage
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF TREATING AN UNDESIRED IMMUNE RESPONSE BY BLOCKING THE BI...
- Publication number 20030091564
- Publication date May 15, 2003
- RICHARD J. ARMITAGE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Richard J. ARMITAGE

Person

Patents Grantslast 30 patents

BCMA antigen binding proteins

BCMA Antigen binding proteins

Human CD30 ligand antigen binding proteins

Anti-interleukin-4 receptor antibodies

BCMA antigen binding proteins

Anti-interleukin-4 receptor antibodies

ULBP2 polypeptides

ULBP antibodies

ULBP antibodies

CD40-Ligand lacking native-pattern glycosylation

Mouse CD40 ligand-specific antibodies and hybridomas

CD30 ligand

ULBP antibodies

ULBP DNA and polypeptides

CD30 ligand

ULBP DNA and polypeptides

Defective CD4&#x0002B;T-cells that express active CD40-L

ULBP DNA and polypeptides

DNA encoding CD40 ligand, a cytokine that binds CD40

Use of CD40 ligand, a cytokine that binds CD40, to stimulate hybrid...

Method of augmenting a vaccine response by administering CD40 ligand

Methods of inhibiting CD40L binding to CD40 with soluble monomeric...

CD30 ligand oligomers and polypeptides

Treatment of individuals exhibiting defective CD40L

CD40 ligand polypeptide

DNA encoding CD40 ligand, a cytokine that binds CD40

Monoclonal antibodies to CD40 ligand, pharmaceutical composition co...

Recombinant soluble CD40 ligand polypeptide and pharmaceutical comp...

Isolated Epstein-Barr virus BZLF2 proteins that bind MHC class II ....

Antibodies to CD40

Patents Applicationslast 30 patents

HUMAN CD30 LIGAND ANTIGEN BINDING PROTEINS

USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF

BCMA ANTIGEN BINDING PROTEINS

USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF

BCMA ANTIGEN BINDING PROTEINS

USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF

Human CD30 Ligand Antigen Binding Proteins

BCMA ANTIGEN BINDING PROTEINS

BCMA ANTIGEN BINDING PROTEINS

USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF

ULBP ANTIBODIES

USE OF INTERLEUKIN-4 ANTAGONISTS AND COMPOSITIONS THEREOF

ULBP antibodies

CD30 Ligand

ULBP antibodies

CD 30 ligand

ULBP antibodies

CD40-Ligand lacking native-pattern glycosylation

ULBP DNA and polypeptides

CD40-Ligand lacking native-pattern glycosylation

METHODS OF TREATING AN UNDESIRED IMMUNE RESPONSE BY BLOCKING THE BI...

Defective CD4+T-cells that express active CD40-L